- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Recognizing Science using the Data Quality Act
Published in 2008
The federal government, and the U.S. Department of Human Services (HHS) in particular, refute the medical benefits of marijuana and disseminate information to the public that marijuana has no medical value. The problem is that the federal government is basing its position on inaccurate and incomplete information about marijuana's medical efficacy. There exists more than enough evidence domestically and internationally to show that marijuana has benefitted countless people in the U.S. and elsewhere in the world.
ASA launched a legal challenge to HHS in October 2004 to correct published medical marijuana misinformation under the Data Quality Act (DQA), a little-known law that requires federal agencies to rely on sound science. The DQA requires federal agencies, like HHS, to use reliable science when making regulations and disseminating information.
On April 20, 2005, HHS denied ASA's petition, but we quickly filed an appeal. After eight letters of delay, HHS finally denied ASA's appeal in July 2006. ASA has since filed a lawsuit in federal court seeking judicial review of the decision by HHS to deny the ASA petition. That lawsuit was dismissed because the district court found that the Data Quality Act does not provide for judicial review, which prompted ASA to appeal the case to the Ninth Circuit Court of Appeals. The case is now fully briefed and was argued on April 14, 2009. If we prevail with our DQA lawsuit, HHS and the federal government will have to change its position on medical marijuana and publicly admit that marijuana is now routinely used for medical treatment, clearing the way for doctors to prescribe it to their patients.
Review ASA's DQA petition, the delay letters from HHS and the government's denial of the petition and appeal here.
Data Quality Act Briefs
Fact Sheet on ASA's Data Quality Act Petition to HHS
ASA Data Quality Act petition to HHS
Information on Lawyers and Named Patients in the Data Quality Act Lawsuit